Search results for "63"

showing 10 items of 724 documents

Luonnontieteellisin analyysimenetelmin tunnistettu Akseli Gallen-Kallelan väripaletti

2020

Artikkeli on kokonaisuudessaan ensimmäinen laatuaan Suomessa ja se esittelee tutkimuksen tuloksia koskien Akseli Gallen-Kallelan käyttämiä väriaineita. Tutkimusaineisto on läpileikkaus taiteilijan taiteellisesta tuotannosta vuosilta 1880–1929.  Se koostuu 265:stä maalauksesta ja 83:sta öljy- ja temperavärituubista. Tutkimuksessa käytetyt analyysimentelmät ovat ainetta tuhoamattomia luonnontieteellisiä analyysimenetelmiä: energiadispersiivinen röntgenfluoresenssi spektroskopia (EDXRF) ja polarisaatiomikroskopia (PLM).
  
 Avainsanat: Akseli Gallen-Kallela, taiteilijatarvike, väriaine, pigmentti, taiteen materiaalitutkimus, EDXRF, polarisaatiomikroskopia.

materiaalitutkimustaiteilijatväriaineetöljymaalauspolarisaatiomikroskopiataidehistoriaGallen-Kallela AkseliArtikkelitlcsh:NX440-632lcsh:History of the artspigmentit (värijauheet)EDXRFmaalaustaideTahiti
researchProduct

Ruolo citotossico del cannabinoide sintetico WIN55,212-2 in cellule di osteosarcoma MG63: coinvolgimento della proteina SPARC.

Il cannabinoide sintetico WIN 55,212-2 è un potente agonista sintetico del recettore per i cannabinoidi con spiccate potenzialità antitumorali. Gli esperimenti riportati in questa tesi sono stati condotti per delineare gli effetti indotti dal WIN sulla proliferazione, la migrazione e la sensibilizzazione alla morte indotta dalla citochina TRAIL in cellule di osteosarcoma umano MG63. I risultati ottenuti mostrano che il WIN induce un blocco del ciclo cellulare in fase G2/M che è associato all’induzione dei principali markers di ER stress (GRP78, CHOP e TRB3). Nelle cellule trattate abbiamo inoltre osservato la conversione della forma citosolica del marker autofagosomale LC3-I in LC3-II (la f…

meccanismi di morte cellularemiR-29-b1Settore BIO/10 - BiochimicaMG63ER streSPARCcannabinoidiPAR-4
researchProduct

Percepción de la seguridad alimentaria por las familias valencianas

2018

media 26 55riesgoJosé seguridad alimentarialabellingfood security and safetyetiquetadocomunicación1696-1676 2341 Quaderns de ciències socials 520636 2018 39 6969543 Percepción de la seguridad alimentaria por las familias valencianas Vázquez Garcíaelecciónchoicerisk
researchProduct

On the social meanings inherent in literacy campaigns

1990

Artikkelissa tarkastellaan luku- ja kirjoitustaitokampanjoita käsittelevän kansainvälisen dokumenttiaineiston perusteella sitä, millaisia merkityksiä sisältyy lukuja kirjoitustaidottomuuden määrittelyyn yhteiskunnalliseksi ongelmaksi, ja asetetaan kyseenalaiseksi tässä aineistossa ilmenevä yleismaailmallinen ideologia. Lisäksi pohditaan luku- ja kirjoitustaidon mahdollisista emansipatorista merkitystä kehitysmaiden oloissa.

media_common.quotation_subjectsosiaalinen muutos [http://www.yso.fi/onto/yso/p7906]Developing countryyhteiskuntakehitys [http://www.yso.fi/onto/yso/p9763]General MedicineGeneral ChemistrySocial issuesLiteracykielipelit [http://www.yso.fi/onto/ysa/Y96142]lukutaito [http://www.yso.fi/onto/ysa/Y96992]IdeologySociologyArtikkelitSocial sciencekehitysyhteistyö [http://www.yso.fi/onto/yso/p3845]Functional illiteracymedia_commonAikuiskasvatus
researchProduct

Antithrombotics and new interventions for venous thromboembolism: Exploring possibilities beyond factor IIa and factor Xa inhibition.

2021

Abstract Direct oral anti–activated factor X and antithrombin agents have largely replaced vitamin K antagonists as the standard of care in treatment of venous thromboembolism. However, gaps in efficacy and safety persist, notably in end‐stage renal disease, implantable heart valves or assist devices, extracorporeal support of the circulation, and antiphospholipid syndrome. Inhibition of coagulation factor XI (FXI) emerges as a promising new therapeutic target. Antisense oligonucleotides offer potential advantages as a prophylactic or therapeutic modality, with one dose‐finding trial in orthopedic surgery already published. In addition, monoclonal antibodies blocking activation and/or activ…

medicine.drug_class2720 Hematologyvenous thromboembolism610 Medicine & healthBioinformaticslaw.inventionchemistry.chemical_compoundRandomized controlled trialAntiphospholipid syndromelawAntithromboticMedicineDiseases of the blood and blood-forming organsFactor XIIbusiness.industrycatheter(s)Factor X10031 Clinic for AngiologyAntithrombinAnticoagulantanticoagulantHematologycontact systemmedicine.diseasefactor XIPulmonary embolismchemistryRC633-647.5businessState of the Art Isth 2020medicine.drugResearch and practice in thrombosis and haemostasis
researchProduct

Orthostatic hypotension and health outcomes: an umbrella review of observational studies

2019

To investigate potential relationships between orthostatic hypotension (OH) and negative health outcomes and mortality, through an umbrella review with integrated meta-analyses. Orthostatic hypotension is significantly associated with several negative outcomes in older people, but a suggestive evidence is available only for higher risk of coronary heart disease congestive heart failure, stroke, falls dementia, and all-cause mortality. Orthostatic hypotension seems to be significantly associated with several negative health outcomes in older people, even if only associations with coronary heart disease, congestive heart failure, stroke, falls, dementia, and all-cause mortality are supported …

medicine.medical_specialty030214 geriatricsHeart diseasebusiness.industrymedicine.diseaseLower riskan umbrella review of observational studies- EUROPEAN GERIATRIC MEDICINE cilt.10 ss.863-870 2019 [SOYSAL P. Veronese N. Smith L. Torbahn G. Jackson S. E. Yang L. Ungar A. Rivasi G. Rafanelli M. Petrovic M. et al. -Orthostatic hypotension and health outcomes]03 medical and health sciencesOrthostatic vital signs0302 clinical medicineHeart failureInternal medicineMeta-analysismedicineDementiaObservational study030212 general & internal medicinebusinessStrokeOrthostatic hypotension · Umbrella review · Meta-analysis · Mortality · Fall · Heart failure · Heart disease · Stroke
researchProduct

Should Contact Bans Have Been Lifted More in Germany?

2020

Abstract Many countries consider the lifting of restrictions of social contacts (RSC). We quantify the effects of RSC for Germany. We initially employ a purely statistical approach to predicting prevalence of Covid-19 if RSC had been upheld after 20 April. We employ these findings and feed them into our theoretical model. We find that the peak of the number of sick individuals would have been reached already end of April. The number of sick individuals would have fallen below 1000 at the beginning of July. If restrictions had been lifted completely on April 20, the number of sick should have risen quickly again from around 27 April. A balance between economic and individual costs of RSC and…

medicine.medical_specialty2019-20 coronavirus outbreakEconomics and EconometricsCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Geography Planning and Developmentforecast Germanyepidemic03 medical and health sciences0302 clinical medicine0502 economics and businessPandemicmedicine030212 general & internal medicineChromatin structure remodeling (RSC) complex050207 economicsExit strategybiologyI18SARS-CoV-2Public healthJel/E17pandemic05 social sciencesE17Jel/I18ArticlesEconomic benefitsEditor's ChoiceC63biology.proteinDemographic economicsJel/C63BusinessCovid-19Cesifo Economic Studies
researchProduct

INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

2021

Objective: An integrated analysis based on the Phase 2 TITAN (NCT01151423) and Phase 3 HERCULES (NCT02553317) studies with caplacizumab (CPLZ) in acquired thrombotic thrombocytopenic purpura (aTTP) was performed to assess treatment differences on efficacy and safety outcomes that may have been undetected in the individual trials. Methodology: In both trials, patients with an acute episode of aTTP were randomized to receive CPLZ or placebo (PBO) in addition to therapeutic plasma exchange (TPE) and immunosuppression. All randomized patients from both studies were included in the integrated efficacy analyses (CPLZ: n=108; PBO: n=112), and those who received at least 1 dose of the study drug we…

medicine.medical_specialtyAcquired Thrombotic Thrombocytopenic PurpuraExacerbationbusiness.industrymedicine.medical_treatmentHazard ratioImmunosuppressionHematologyPlaceboGastroenterologyRefractoryInternal medicinemedicineImmunology and AllergyDiseases of the blood and blood-forming organsPlateletRC633-647.5CaplacizumabbusinessHematology, Transfusion and Cell Therapy
researchProduct

Thrombosis and thromboembolism related to COVID‐19: A clarion call for obtaining solid estimates from large‐scale multicenter data

2020

Abstract The clinical spectrum of coronavirus disease 2019 (COVID‐19) is wide, ranging from minor, nonspecific symptoms to severe pneumonia, acute respiratory distress syndrome, multiorgan involvement, and shock. In severe cases, the acute systemic inflammatory response, coagulation activation, and diffuse endothelial damage may, in combination with hypoxia, immobilization, and underlying risk factors, result in potentially life‐threatening venous and arterial thrombotic events. The first data from single‐center retrospective studies suggest that thrombotic events are a key aspect of COVID‐19‐associated morbidity and mortality. We have planned and will be launching the COvid REgistry on THR…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Hospitalized patientsvenous thromboembolism610 Medicine & healthAcute respiratory distressregistrymedicine.disease_causeSARS‐CoV‐2COVID‐19Internal medicineMedicineIn patientthrombosisCoronavirusCOVIDbusiness.industryForumlcsh:RC633-647.510031 Clinic for AngiologyRetrospective cohort studyHematologylcsh:Diseases of the blood and blood-forming organsHypoxia (medical)medicine.diseaseThrombosismedicine.symptombusinessResearch and Practice in Thrombosis and Haemostasis
researchProduct

Novel missense mutation of the TP63 gene in a newborn with Hay-Wells/Ankyloblepharon-Ectodermal defects-Cleft lip/palate (AEC) syndrome: clinical rep…

2021

Abstract Introduction Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome, also known as Hay-Wells syndrome, is a rare genetic syndrome with ectodermal dysplasia. About 100 patients have been reported to date. It is associated to a heterozygous mutation of the tumor protein p63 (TP63) gene, located on chromosome 3q28. Typical clinical manifestations include: filiform ankyloblepharon adnatum (congenital adherence of the eyelids), ectodermal abnormalities (sparse and frizzy hair, skin defects, nail alterations, dental changes and hypohidrosis), and cleft lip/palate. Diagnostic suspicion is based on clinical signs and confirmed by genetic testing. Patient’s presentation We hereb…

medicine.medical_specialtyEctodermal dysplasiaHay–Wells syndromeCleft LipAnkyloblepharonMutation MissenseErythrodermaCase ReportEctodermal dysplasiaPediatricsRJ1-570TP63medicineMissense mutationHumansEye Abnormalitiesbusiness.industryTumor Suppressor ProteinsAEC syndromeInfant NewbornTumor protein p63 geneEyelidsmedicine.diseaseAnkyloblepharon-ectodermal defects-cleft lip/palate syndromeDermatologyCleft Palatemedicine.anatomical_structureHay-Wells syndromeScalpAgenesisFemaleAEC syndrome Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome Congenital skin disorders Ectodermal dysplasia Hay-Wells syndrome Tumor protein p63 genebusinessTranscription FactorsCongenital skin disordersItalian journal of pediatrics
researchProduct